CMS Authority For Least Costly Alternative On Drugs Coming Soon – Sen. Roberts
This article was originally published in The Pink Sheet Daily
Executive Summary
Kansas senator expresses concern that LCA authority, combined with comparative effectiveness, could blur the lines between FDA and CMS.